Strata Critical Medical (SRTA) Operating Leases (2020 - 2026)

Strata Critical Medical (SRTA) has reported Operating Leases for 7 consecutive years, with $3.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Operating Leases fell 38.99% year-over-year to $3.5 million; the TTM figure through Mar 2026 stood at $3.5 million (down 38.99% YoY), while the FY2025 annual figure was $2.7 million, up 13.66% from the prior year.
• Operating Leases rose to $3.5 million in Q1 2026 per SRTA's latest filing, from $2.7 million in the prior quarter.
• Across five years, Operating Leases topped out at $25.5 million in Q1 2024 and bottomed at $466000.0 in Q1 2022.
• Historically, Operating Leases has averaged $12.2 million across 5 years, with a median of $15.0 million in 2022.
• Annual changes were most pronounced in 2022 — Operating Leases jumped 7622.07% — and 2024, when it slumped 88.16%.
• Strata Critical Medical's Operating Leases stood at $15.0 million in 2022, then jumped by 31.85% to $19.7 million in 2023, then plunged by 88.16% to $2.3 million in 2024, then grew by 13.66% to $2.7 million in 2025, then jumped by 31.11% to $3.5 million in 2026.
• Business Quant data shows SRTA's Operating Leases at $3.5 million in Q1 2026, $2.7 million in Q4 2025, and $2.8 million in Q3 2025.